Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Certara, Inc. (CERT) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Certara, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1827090.
Total stock buying since 2020: $1,908,092.
Total stock sales since 2020: $1,609,836,028.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 223,644 | $0 |
| 2024 | 0 | $0 | 74,060 | $940,700 | 140,106 | $0 |
| 2023 | 5,000 | $79,057 | 101,328 | $1,789,961 | 145,403 | $0 |
| 2022 | 45,000 | $742,400 | 9,659,914 | $176,231,609 | 0 | $0 |
| 2021 | 0 | $0 | 40,245,769 | $1,124,567,717 | 0 | $0 |
| 2020 | 47,245 | $1,086,635 | 14,167,717 | $306,306,041 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 0 | $0 | 0 | $0 | 112,251 | $0 |
| 2025-04 | 0 | $0 | 0 | $0 | 111,393 | $0 |
| 2024-10 | 0 | $0 | 5,409 | $59,661 | 7,151 | $0 |
| 2024-09 | 0 | $0 | 51,224 | $578,318 | 0 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 34,652 | $0 |
| 2024-04 | 0 | $0 | 17,427 | $302,721 | 98,303 | $0 |
| 2023-12 | 0 | $0 | 6,000 | $108,000 | 0 | $0 |
| 2023-09 | 0 | $0 | 51,224 | $747,870 | 0 | $0 |
| 2023-08 | 5,000 | $79,057 | 0 | $0 | 0 | $0 |
| 2023-06 | 0 | $0 | 19,104 | $411,691 | 0 | $0 |
| 2023-05 | 0 | $0 | 5,000 | $104,100 | 54,952 | $0 |
| 2023-04 | 0 | $0 | 5,000 | $118,300 | 0 | $0 |
| 2023-03 | 0 | $0 | 0 | $0 | 90,451 | $0 |
| 2023-02 | 0 | $0 | 15,000 | $300,000 | 0 | $0 |
| 2022-11 | 0 | $0 | 403,669 | $6,280,788 | 0 | $0 |
| 2022-08 | 45,000 | $742,400 | 6,196,893 | $107,705,299 | 0 | $0 |
| 2022-06 | 0 | $0 | 760,000 | $14,856,350 | 0 | $0 |
| 2022-05 | 0 | $0 | 1,500,000 | $28,500,000 | 0 | $0 |
| 2022-04 | 0 | $0 | 3,352 | $74,716 | 0 | $0 |
| 2022-03 | 0 | $0 | 343,000 | $6,931,101 | 0 | $0 |
| 2022-02 | 0 | $0 | 215,000 | $5,332,250 | 0 | $0 |
| 2022-01 | 0 | $0 | 238,000 | $6,551,105 | 0 | $0 |
| 2021-12 | 0 | $0 | 325,500 | $9,074,622 | 0 | $0 |
| 2021-11 | 0 | $0 | 8,868,470 | $264,833,871 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-30 | Corcoran Daniel (SVP and General Counsel) | Option Ex | 22,828 | .00 | 0 |
| 2025-05-30 | Anhalt Rona (Chief Human Resources Officer) | Option Ex | 7,146 | .00 | 0 |
| 2025-05-21 | Reynders John V W | Option Ex | 10,709 | .00 | 0 |
| 2025-05-21 | Killefer Nancy | Option Ex | 11,928 | .00 | 0 |
| 2025-05-21 | Crane Rosemary A | Option Ex | 11,928 | .00 | 0 |
| 2025-05-21 | Collins Cynthia | Option Ex | 11,928 | .00 | 0 |
| 2025-05-21 | Walsh Matthew M | Option Ex | 11,928 | .00 | 0 |
| 2025-05-21 | Broshy Eran | Option Ex | 11,928 | .00 | 0 |
| 2025-05-21 | Cashman James E Iii | Option Ex | 11,928 | .00 | 0 |
| 2025-04-01 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Option Ex | 111,393 | .00 | 0 |
| 2024-10-07 | Smith Patrick F (PRESIDENT, DRUG DEV SOLUTIONS) | Sale | 5,409 | 11.03 | 59,661 |
| 2024-10-04 | Smith Patrick F (PRESIDENT, DRUG DEV SOLUTIONS) | Option Ex | 7,151 | .00 | 0 |
| 2024-09-09 | Pedersen Leif E (PRESIDENT, CHIEF COMMERCAL OFF) | Sale | 51,224 | 11.29 | 578,318 |
| 2024-05-21 | Killefer Nancy | Option Ex | 8,663 | .00 | 0 |
| 2024-05-21 | Crane Rosemary A | Option Ex | 8,663 | .00 | 0 |
| 2024-05-21 | Collins Cynthia | Option Ex | 8,663 | .00 | 0 |
| 2024-05-21 | Cashman James E Iii | Option Ex | 8,663 | .00 | 0 |
| 2024-04-02 | Smith Patrick F (PRESIDENT, DRUG DEV SOLUTIONS) | Sale | 14,427 | 17.24 | 248,721 |
| 2024-04-01 | Smith Patrick F (PRESIDENT, DRUG DEV SOLUTIONS) | Option Ex | 16,498 | .00 | 0 |
| 2024-04-01 | Sherman Nicolette D (CHIEF HUMAN RESOURCES OFFICER) | Option Ex | 8,219 | .00 | 0 |
| 2024-04-01 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 3,000 | 18.00 | 54,000 |
| 2024-04-01 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Option Ex | 13,295 | .00 | 0 |
| 2024-04-01 | Aspbury Robert (PRESIDENT; SCIENTIFIC SOFTWARE) | Option Ex | 16,498 | .00 | 0 |
| 2024-04-01 | Gallagher John E (CHIEF FINANCIAL OFFICER) | Option Ex | 27,295 | .00 | 0 |
| 2024-04-01 | Pedersen Leif E (PRESIDENT, CHIEF COMMERCAL OFF) | Option Ex | 16,498 | .00 | 0 |
| 2023-12-26 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 6,000 | 18.00 | 108,000 |
| 2023-09-11 | Pedersen Leif E (PRESIDENT, CHIEF COMMERCAL OFF) | Sale | 51,224 | 14.60 | 747,870 |
| 2023-08-22 | Broshy Eran | Buy | 4,807 | 15.80 | 75,950 |
| 2023-08-21 | Broshy Eran | Buy | 193 | 16.10 | 3,107 |
| 2023-06-05 | Smith Patrick F (PRESIDENT, INTEGRATED DRUG DEV) | Sale | 19,104 | 21.55 | 411,691 |
| 2023-05-23 | Crane Rosemary A | Option Ex | 9,324 | .00 | 0 |
| 2023-05-23 | Broshy Eran | Option Ex | 9,360 | .00 | 0 |
| 2023-05-17 | Killefer Nancy | Option Ex | 9,067 | .00 | 0 |
| 2023-05-17 | Collins Cynthia | Option Ex | 9,067 | .00 | 0 |
| 2023-05-17 | Walsh Matthew M | Option Ex | 9,067 | .00 | 0 |
| 2023-05-17 | Cashman James E Iii | Option Ex | 9,067 | .00 | 0 |
| 2023-05-11 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 5,000 | 20.82 | 104,100 |
| 2023-04-14 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 5,000 | 23.66 | 118,300 |
| 2023-03-31 | Virkler Drayton (PRESIDENT, REG & ACCES) | Option Ex | 3,990 | .00 | 0 |
| 2023-03-31 | Smith Patrick F (PRESIDENT, INTEGRATED DRUG DEV) | Option Ex | 8,646 | .00 | 0 |
| 2023-03-31 | Sherman Nicolette D (CHIEF HUMAN RESOURCES OFFICER) | Option Ex | 3,990 | .00 | 0 |
| 2023-03-31 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Option Ex | 6,651 | .00 | 0 |
| 2023-03-31 | Schemick Michael Andrew (CHIEF FINANCIAL OFFICER) | Option Ex | 13,302 | .00 | 0 |
| 2023-03-31 | Aspbury Robert (PRESIDENT, SIMCYP) | Option Ex | 8,646 | .00 | 0 |
| 2023-03-31 | Pedersen Leif E (PRESIDENT, SOFTWARE) | Option Ex | 8,646 | .00 | 0 |
| 2023-03-31 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Option Ex | 36,580 | .00 | 0 |
| 2023-02-02 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 15,000 | 20.00 | 300,000 |
| 2022-11-22 | Pedersen Leif E (PRESIDENT, SOFTWARE) | Sale | 102,446 | 15.55 | 1,593,034 |
| 2022-11-15 | Slaine Mason P | Sale | 245,793 | 15.57 | 3,826,997 |
| 2022-11-14 | Slaine Mason P | Sale | 4,207 | 15.27 | 64,240 |
| 2022-08-19 | Mclean Stephen M. | Buy | 20,000 | 16.32 | 326,400 |
| 2022-08-17 | Schemick Michael Andrew (CHIEF FINANCIAL OFFICER) | Buy | 25,000 | 16.64 | 416,000 |
| 2022-08-16 | Smith Patrick F (PRESIDENT, INTEGRATED DRUG DEV) | Sale | 10,000 | 17.71 | 177,100 |
| 2022-08-16 | Eqt Fund Management S.a R.l. | Sale | 6,004,418 | 17.38 | 104,356,784 |
| 2022-08-16 | Slaine Mason P | Sale | 182,475 | 17.38 | 3,171,415 |
| 2022-06-08 | Smith Patrick F (PRESIDENT, INTEGRATED DRUG DEV) | Sale | 10,000 | 19.16 | 191,600 |
| 2022-06-02 | Slaine Mason P | Sale | 500,000 | 19.55 | 9,776,500 |
| 2022-05-31 | Eqt Fund Management S.a R.l. | Sale | 1,500,000 | 19.00 | 28,500,000 |
| 2022-04-04 | Smith Patrick F (PRESIDENT, INTEGRATED DRUG DEV) | Sale | 3,352 | 22.29 | 74,716 |
| 2022-03-17 | Slaine Mason P | Sale | 125,000 | 20.25 | 2,531,250 |
| 2022-03-16 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 3,000 | 20.00 | 60,000 |
| 2022-03-16 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 62,485 | 20.17 | 1,260,322 |
| 2022-03-16 | Slaine Mason P | Sale | 125,000 | 20.17 | 2,521,250 |
| 2022-03-11 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 27,515 | 20.29 | 558,279 |
| 2022-02-18 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 75,000 | 23.62 | 1,771,500 |
| 2022-02-17 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 90,000 | 24.75 | 2,227,500 |
| 2022-02-01 | Slaine Mason P | Sale | 50,000 | 26.66 | 1,333,250 |
| 2022-01-26 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 3,000 | 26.01 | 78,030 |
| 2022-01-26 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 75,000 | 25.20 | 1,889,625 |
| 2022-01-20 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 5,000 | 27.50 | 137,500 |
| 2022-01-18 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 5,000 | 27.44 | 137,200 |
| 2022-01-03 | Slaine Mason P | Sale | 100,000 | 28.73 | 2,872,500 |
| 2021-12-27 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 3,000 | 29.30 | 87,900 |
| 2021-12-23 | Cashman James E Iii | Sale | 25,111 | 29.20 | 733,241 |
| 2021-12-22 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 75,000 | 28.58 | 2,143,500 |
| 2021-12-22 | Cashman James E Iii | Sale | 19,889 | 29.00 | 576,781 |
| 2021-12-20 | Choe Jieun W. (CHIEF STRATEGY & MARKETING) | Sale | 7,500 | 28.00 | 210,000 |
| 2021-12-17 | Choe Jieun W. (CHIEF STRATEGY & MARKETING) | Sale | 5,000 | 26.13 | 130,650 |
| 2021-12-13 | Slaine Mason P | Sale | 50,000 | 28.30 | 1,415,000 |
| 2021-12-07 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 70,000 | 27.70 | 1,939,000 |
| 2021-12-03 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 70,000 | 26.27 | 1,838,550 |
| 2021-11-24 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 145,000 | 28.53 | 4,136,850 |
| 2021-11-22 | Eqt Fund Management S.a R.l. | Sale | 8,117,655 | 29.74 | 241,427,177 |
| 2021-11-22 | Slaine Mason P | Sale | 376,149 | 29.74 | 11,187,047 |
| 2021-11-19 | Choe Jieun W. (CHIEF STRATEGY & MARKETING) | Sale | 20,000 | 30.30 | 606,000 |
| 2021-11-19 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 70,000 | 30.31 | 2,121,700 |
| 2021-11-15 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 73,000 | 38.47 | 2,808,456 |
| 2021-11-15 | Schemick Michael Andrew (CHIEF FINANCIAL OFFICER) | Sale | 66,666 | 38.20 | 2,546,641 |
| 2021-10-27 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 75,000 | 39.50 | 2,962,500 |
| 2021-10-26 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 3,000 | 39.95 | 119,850 |
| 2021-10-26 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 3,000 | 39.95 | 119,850 |
| 2021-10-21 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 6,116 | 38.60 | 236,077 |
| 2021-10-20 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 12,674 | 38.58 | 488,962 |
| 2021-10-19 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 1,210 | 38.55 | 46,645 |
| 2021-10-19 | Choe Jieun W. (CHIEF STRATEGY & MARKETING) | Sale | 20,000 | 37.92 | 758,400 |
| 2021-10-18 | Schemick Michael Andrew (CHIEF FINANCIAL OFFICER) | Sale | 66,667 | 36.88 | 2,458,345 |
| 2021-10-15 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 5,000 | 37.38 | 186,900 |
| 2021-10-15 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 5,000 | 37.38 | 186,900 |
| 2021-10-01 | Aspbury Robert (PRESIDENT, SIMCYP) | Sale | 19,354 | 33.81 | 654,455 |
| 2021-09-27 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 3,000 | 36.00 | 108,000 |
| 2021-09-27 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 3,000 | 36.00 | 108,000 |
| 2021-09-22 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 75,000 | 36.53 | 2,740,124 |
| 2021-09-20 | Schemick Michael Andrew (CHIEF FINANCIAL OFFICER) | Sale | 66,667 | 34.74 | 2,316,344 |
| 2021-09-17 | Choe Jieun W. (CHIEF STRATEGY & MARKETING) | Sale | 20,000 | 35.64 | 712,800 |
| 2021-09-13 | Eqt Fund Management S.a R.l. | Sale | 13,394,635 | 29.80 | 399,146,728 |
| 2021-09-13 | Slaine Mason P | Sale | 620,668 | 29.80 | 18,495,285 |
| 2021-09-09 | Pedersen Leif E (PRESIDENT, SOFTWARE) | Sale | 51,223 | 34.33 | 1,758,280 |
| 2021-09-02 | Rayner Craig R. (PRESIDENT, INTEGRATED DRUG DEV) | Sale | 54,462 | 35.38 | 1,926,756 |
| 2021-09-01 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 30,000 | 33.86 | 1,015,800 |
| 2021-09-01 | Aspbury Robert (PRESIDENT, SIMCYP) | Sale | 19,354 | 34.00 | 658,036 |
| 2021-08-30 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 9,000 | 33.50 | 301,500 |
| 2021-08-25 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 75,000 | 31.23 | 2,341,875 |
| 2021-08-24 | Choe Jieun W. (CHIEF STRATEGY & MARKETING) | Sale | 7,500 | 30.00 | 225,000 |
| 2021-08-19 | Choe Jieun W. (CHIEF STRATEGY & MARKETING) | Sale | 12,500 | 28.34 | 354,250 |
| 2021-08-16 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 8,000 | 28.58 | 228,640 |
| 2021-08-16 | Schemick Michael Andrew (CHIEF FINANCIAL OFFICER) | Sale | 66,667 | 28.55 | 1,903,676 |
| 2021-08-16 | Edge Justin (PRES., REGULATORY & ACCESS) | Sale | 5,000 | 28.58 | 142,900 |
| 2021-08-11 | Aspbury Robert (PRESIDENT, SIMCYP) | Sale | 19,354 | 27.54 | 533,009 |
| 2021-08-02 | Eqt Fund Management S.a R.l. | Sale | 7,252,632 | 26.00 | 188,568,432 |
| 2021-07-28 | Feehery William F (CHIEF EXECUTIVE OFFICER) | Sale | 75,000 | 26.16 | 1,962,000 |
| 2021-07-26 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 3,000 | 26.27 | 78,810 |
| 2021-07-19 | Schemick Michael Andrew (CHIEF FINANCIAL OFFICER) | Sale | 66,667 | 24.37 | 1,624,674 |
| 2021-07-01 | Aspbury Robert (PRESIDENT, SIMCYP) | Sale | 19,354 | 28.03 | 542,492 |
| 2021-06-28 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 3,000 | 28.38 | 85,140 |
| 2021-06-24 | Traynor Richard M. (SVP AND GENERAL COUNSEL) | Sale | 5,000 | 26.37 | 131,850 |
| 2021-06-22 | Schemick Michael Andrew (CHIEF FINANCIAL OFFICER) | Sale | 66,666 | 26.94 | 1,795,982 |
| 2021-06-14 | Aspbury Robert (PRESIDENT, SIMCYP) | Sale | 19,354 | 27.80 | 538,041 |
| 2021-06-11 | Rayner Craig R. (PRESIDENT, INTEGRATED DRUG DEV) | Sale | 108,924 | 26.00 | 2,832,024 |
| 2021-03-29 | Eqt Fund Management S.a R.l. | Sale | 8,674,151 | 24.12 | 209,263,892 |
| 2020-12-15 | Traynor Richard M. (SVP and General Counsel) | Buy | 245 | 23.00 | 5,635 |
| 2020-12-15 | Mclean Stephen M. | Buy | 22,000 | 23.00 | 506,000 |
| 2020-12-15 | Eqt Fund Management S.a R.l. | Sale | 14,167,717 | 21.62 | 306,306,041 |
| 2020-12-15 | Walsh Matthew M | Buy | 5,000 | 23.00 | 115,000 |
| 2020-12-15 | Cashman James E Iii | Buy | 20,000 | 23.00 | 460,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CERT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Certara, Inc. (symbol CERT, CIK number 1827090) see the Securities and Exchange Commission (SEC) website.